Oxytocin Acetate 5mg

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

Oxytocin is a naturally occurring nonapeptide (9-amino-acid hormone) and oxytocin-receptor (OXTR) agonist, best known for driving uterine contraction and milk let-down and for acting centrally as a social-bonding neuromodulator[1][2]. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. The injectable form is FDA/EMA-approved only for obstetric use (labor induction and postpartum bleeding, given IV/IM by clinicians); subcutaneous or intranasal oxytocin for social, mood or wellness goals is off-label and research-only, with weak and largely negative human evidence, and vendor research-chemical oxytocin is not a quality-assured medicine — presented for research and educational use only.

Add 3.0 mL bacteriostatic water to one 5 mg vial → ~1.67 mg/mL (1,667 mcg/mL; about 833 IU/mL), a large dilution chosen for accurate dosing.
100–500 mcg once daily, titrated upward gradually across an 8–12 week research course (social/wellness use is off-label and unproven).
At ~1.67 mg/mL, 1 unit ≈ 16.7 mcg; 100 mcg ≈ 6 units and 500 mcg ≈ 30 units on a U-100 syringe.
Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Phase / Week(s)	Dose & Frequency	Volume (U-100 units / mL)
Weeks 1–2	100 mcg (1× daily)	6 units (0.06 mL)
Weeks 3–4	200 mcg (1× daily)	12 units (0.12 mL)
Weeks 5–6	300 mcg (1× daily)	18 units (0.18 mL)
Weeks 7–8	400 mcg (1× daily)	24 units (0.24 mL)
Weeks 9–12	500 mcg (1× daily)	30 units (0.30 mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 5 mg vial → final concentration ~1.67 mg/mL (1,667 mcg/mL; ~833 IU/mL).
Typical daily range: 100–500 mcg once daily, raised gradually over an 8–12 week research course.
Easy measuring: At ~1.67 mg/mL, 1 unit ≈ 16.7 mcg on a U-100 syringe (~1 IU ≈ 2 mcg). The 3.0 mL dilution keeps the starting 100 mcg dose at a readable 6 units.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
Frequency: one subcutaneous injection each day, titrating up as tolerated and rotating sites. Oxytocin has a very short half-life (minutes), so any effect from a dose is acute[3][4]. These figures come from off-label research protocols, not from approved human dosing — the only approved oxytocin dosing is obstetric and clinician-administered.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

Release it slowly down the vial’s inner wall to limit foaming.
Swirl or roll gently until fully dissolved — don’t shake.
Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
The 3.0 mL dilution is deliberately large so each dose reads at 30 units or more, where U-100 syringe markings are most precise. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course of once-daily injections with gradual titration.

A 5 mg vial lasts well over a week at these microgram doses (100–500 mcg/day); plan a few vials per research cycle.
8 weeks: ~3 vials
12 weeks: ~6 vials
16 weeks: ~9 vials
Per injection: 1 syringe
8 weeks (once daily): ~56 syringes
16 weeks (once daily): ~112 syringes
Use ~3.0 mL per 5 mg vial for reconstitution.
8 weeks (3 vials): ~9 mL → 1 bottle
16 weeks (9 vials): ~27 mL → 3 bottles
One for the vial stopper + one for the injection site each day.
Per injection: 2 swabs
8 weeks (once daily): ~112 swabs → 1–2 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

▪Goal: Explore oxytocin’s receptor-mediated effects on social bonding, stress and mood — outcomes that are off-label and largely unproven in humans[2][5].
▪Schedule: Daily subcutaneous injections for 8–12 weeks, optionally extended to ~16 weeks for longer research goals.
▪Dose Range: 100–500 mcg per day with gradual titration (off-label research dosing).
▪Reconstitution: 3.0 mL bacteriostatic water per 5 mg vial gives ~1.67 mg/mL (~833 IU/mL) for accurate unit measurements.
▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses.

▪Start: Begin at 100 mcg once daily to gauge tolerability.
▪Titrate: Increase by roughly 100 mcg every two weeks as tolerated.
▪Target: Reach about 500 mcg daily by weeks 9–12 (typical upper end of research protocols).
▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
▪Timing: Inject at a consistent time each day and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep daily administration safe and consistent.

▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
▪Regulatory note: Injectable oxytocin is FDA/EMA-approved only for obstetric use (given IV/IM by clinicians); subcutaneous or intranasal use for social, mood or wellness goals is off-label and research-only[6].

How This Works

Oxytocin is a 9-amino-acid hormone (a nonapeptide) that acts as an agonist at the oxytocin receptor (OXTR), a G-protein-coupled receptor expressed in both the brain and peripheral tissues[1][6]. It is produced in the hypothalamus and released from the posterior pituitary.

Peripherally, OXTR activation triggers smooth-muscle contraction — most notably uterine contraction during labor and milk let-down during lactation[1]. These obstetric actions are the basis for oxytocin’s only approved clinical use, where it is given intravenously or intramuscularly by clinicians.
Centrally, oxytocin acts as a neuromodulator implicated in social bonding, trust and stress regulation, partly via interactions with dopamine signalling and the HPA stress axis[2][7]. Importantly, oxytocin does not cross the blood–brain barrier well from the bloodstream, so peripheral (subcutaneous) dosing mainly engages peripheral receptors; intranasal delivery is used in research to try to reach central receptors.
Important caveat: oxytocin has a very short half-life (on the order of minutes), so any effect from a dose is acute. Off-label use for social bonding, anxiety, autism or weight management is research-only, and the human evidence is weak and largely negative — for example, the large SOARS-B trial found no benefit of intranasal oxytocin in autistic children[5][8]. Such claims should be read as hypotheses, not established outcomes.
The approved injectable (Pitocin/Syntocinon) is a quality-assured medicine for obstetric use only. Research-chemical oxytocin sold for self-administration is not an approved medicine and is presented here for research and educational purposes only.

Lifestyle Factors

Habits that may support neuroendocrine function alongside the protocol.

▪Nutrition: Keep a balanced, nutrient-dense diet matched to your energy needs and research goals.
▪Activity & rest: Combine regular aerobic and resistance exercise with adequate recovery to support overall metabolic health.
▪Sleep: Aim for 7–9 hours to support neuroendocrine function and adherence.
▪Stress: Manage stress with evidence-based practices, since it interacts with the same systems oxytocin modulates.

Potential Benefits & Side Effects

What the research literature describes; human evidence is weak, often mixed or negative, and individual results vary.

▪Approved obstetric use: As a uterotonic, oxytocin is established for labor induction/augmentation and postpartum hemorrhage — given IV/IM by clinicians at far different doses than research use[6].
▪Social/anxiety (research): Short-term studies report modest, inconsistent effects on social cognition and anxiety; results are mixed and far from established[2][9].
▪Appetite/metabolism (early): Single intranasal doses have reduced test-meal intake in small studies, but durable weight effects are unproven[10].
▪Note on humans: Many touted benefits are not established — the large SOARS-B autism trial found no benefit of intranasal oxytocin[5].
▪Injection-site reactions: Mild redness, tenderness or soreness can occur; rotating sites helps.
▪Dose-related effects: At higher exposures oxytocin can affect blood pressure, heart rate, fluid balance (antidiuresis/hyponatremia risk) and, via smooth-muscle action, uterine contraction — a particular concern in pregnancy[6].
▪Unproven & unregulated: Research-chemical oxytocin is not a quality-assured medicine and its off-label benefits are not established; caution and monitoring are advised.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14][15].

▪Wash your hands well with soap and water.
▪Wipe the vial stopper with an alcohol swab and let it air-dry.
▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
▪Draw the intended dose, then check for air bubbles and push any out.
▪Pinch a skinfold at the chosen site between thumb and forefinger.
▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
▪Press the plunger slowly and steadily until it’s fully down.
▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
▪Return the reconstituted vial to the fridge right away.
▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
▪Watch the site for excess redness, swelling, or signs of infection.

Recommended Source

For high-purity research peptides, we point researchers to Prime Lab Peptides for research-grade oxytocin (5 mg).

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA. Open source
▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.
▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.
▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.
▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Prime Lab Peptides →

References

Reference-derived details for Oxytocin Acetate 5mg.

Oxytocin (5mg Vial) Dosage Protocol Open source
1 StatPearls / NCBI Bookshelf Oxytocin: nonapeptide structure, OXTR signalling, and physiology of uterine contraction and lactation. View Source ↗ Open source
2 Psychoneuroendocrinology (PubMed) Reviews of oxytocin as a social/bonding neuromodulator; effects on trust and social cognition are modest and inconsistent. View Source ↗ Open source
3 Clinical Pharmacokinetics (PubMed) Oxytocin pharmacokinetics: very short plasma half-life (on the order of minutes). View Source ↗ Open source
4 Journal of Neuroendocrinology (PubMed) Dosing and bioavailability considerations for exogenous oxytocin across routes of administration. View Source ↗ Open source
5 SOARS-B Trial — NEJM Randomized trial of intranasal oxytocin in autistic children found no significant benefit on social function. View Source ↗ Open source
6 FDA Label — Oxytocin (Pitocin) Prescribing information: approved obstetric indications, IV/IM administration, and warnings. View Source ↗ Open source
7 Frontiers in Neuroscience (PubMed) Oxytocin modulation of the HPA stress axis and dopaminergic social-reward circuits. View Source ↗ Open source
8 Neuropsychopharmacology (PubMed) Blood–brain barrier penetration of peripheral oxytocin and rationale for intranasal delivery. View Source ↗ Open source
9 Systematic Review (PubMed) Mixed/largely negative evidence for intranasal oxytocin in anxiety and psychiatric conditions. View Source ↗ Open source
10 Diabetes / Metabolism (PubMed) Single-dose intranasal oxytocin reduced caloric intake in small human studies; durable effects unproven. View Source ↗ Open source
11 Cochrane Review Oxytocin for induction of labour and prevention of postpartum hemorrhage: evidence summary. View Source ↗ Open source
12 Biological Psychiatry (PubMed) Oxytocin trials in psychiatric disorders: small effect sizes and replication concerns. View Source ↗ Open source
13 ClinicalTrials.gov Registry of oxytocin trials across obstetric and investigational social/behavioral indications. View Source ↗ Open source
14 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
15 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
16 Prime Lab Peptides Research-grade peptide supplier — purity specifications and certificates of analysis. View Source ↗ Open source

Contents